Sandoz Comfarol Forte

Comfarol Forte is a prescription-grade analgesic medication produced by Sandoz, a global leader in generic pharmaceuticals. This specific product is a combination therapy consisting of Paracetamol (500mg) and Codeine Phosphate Hemihydrate (30mg), typically used for the relief of moderate to severe pain.

Sandoz has deep historical roots in Switzerland, originating from the chemical company Kern & Sandoz founded in 1886. For decades, it was part of the Novartis group, but as of late 2023, it successfully completed a spin-off to become a fully independent, publicly-traded company. Its operations are global, with a manufacturing footprint that spans several continents, although it remains headquartered in Basel, Switzerland.

The brand is widely recognized for increasing access to high-quality healthcare by providing affordable generic alternatives to off-patent medications. As an independent entity, Sandoz continues to focus on its legacy of Swiss precision while expanding its portfolio in biosimilars and essential generic medicines worldwide.